$3,415.18 consulting Payment -- Teva Pharmaceuticals to Dr. Michael Rodriguez
Pain Management Doctor Receives $3,415 Consulting Fee from Teva Pharmaceuticals for Xtandi
This page provides a detailed analysis of a $3,415.18 consulting payment from Teva Pharmaceuticals to Dr. Michael Rodriguez. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $3,415.18 |
| Payment Type | consulting |
| Payment Nature | Consulting Fee |
| Pharmaceutical Company | Teva Pharmaceuticals |
| Physician | Dr. Michael Rodriguez |
| NPI Number | 1828800913 |
| Physician Specialty | Pain Management |
| Location | Athens, GA |
| Date of Payment | 2024-09-08 |
| Related Drug/Device | Xtandi |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Teva Pharmaceuticals made a $3.4K consulting payment to Michael Rodriguez, a Pain Management specialist in Athens, GA. The payment was associated with Xtandi. Michael Rodriguez received a $3,415.18 consulting fee from Teva Pharmaceuticals on September 8, 2024. The payment was related to consulting services for the drug Xtandi. The payment was made to a Pain Management specialist in Athens, GA.
Patient Guidance: What This Payment Means for You
If you are a patient being treated by Dr. Michael Rodriguez, this payment information may help you understand potential influences on your care, though it does not inherently indicate any impropriety. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Consulting fees for specialists can vary widely based on the nature of the consultation, the company, and the drug or device involved. This amount for a specific consulting engagement is moderate within the broader landscape of physician payments.
Regulatory Context: Sunshine Act Requirements
Payments from pharmaceutical companies to physicians are subject to disclosure under the Sunshine Act (part of the Affordable Care Act) to promote transparency in healthcare.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-compensation
- consulting-fees
- pain-management
- teva-pharmaceuticals
- xtandi
Understanding consulting Payments
Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.
Frequently Asked Questions About This Payment
What was this $3.4K payment for?
This was a consulting payment of $3.4K from Teva Pharmaceuticals to Michael Rodriguez, categorized as "Consulting Fee". It was associated with Xtandi. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Michael Rodriguez accept pharmaceutical money?
Yes, Michael Rodriguez received this $3.4K payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Michael Rodriguez's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this consulting payment?
A consulting payment of $3.4K may reflect legitimate advisory services the physician provides. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Pain Management?
To compare this payment against Pain Management averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Pain Management physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Michael Rodriguez's relationship with Teva Pharmaceuticals?
The payment amount is a specific figure, indicating a defined consulting engagement. This $3.4K consulting payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Pain Management?
The payment type is 'consulting', suggesting an advisory role rather than promotional activity.
What should patients do after learning about this payment?
If you are a patient being treated by Dr. Michael Rodriguez, this payment information may help you understand potential influences on your care, though it does not inherently indicate any impropriety.
What else should I know about this consulting payment?
The drug 'Xtandi' is a prostate cancer treatment, aligning with the Pain Management specialty's potential involvement in palliative care or pain associated with cancer.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.